Ohio firms lead $15M investment in Naples medical tech company

Naples medical technology and device firm Catalyst OrthoScience has raised $15 million in equity and debt financing. The latest round of capital, from a combination of banks, physicians and a venture capital firm, comes a year after the firm raised $20 million in a separate effort.

Catalyst officials say the firm is “redefining shoulder arthroplasty through simplified, surgeon-focused innovation. The company, in a statement, says the “latest round of funding strengthens Catalyst’s balance sheet and positions the company to advance its high-growth commercial and clinical programs.”

The latest capital raise was led by RC Capital, a Cincinnati health care growth equity firm, with participation from Cleveland-based Mutual Capital Partners, Dr. Derace Schaffer and Western Alliance Bank out of Phoenix. RC Capital and Mutual Capital Partners supported the capital raise in 2024 as well. 

“Catalyst epitomizes what can be accomplished by combining continuous innovation with excellence and employee dedication,” says Schaffer, a physician, entrepreneur and long-time Catalyst investor and board member, in the release. “As an investor and board member across many public and private health care companies, I've seen how important it is for a team to execute with both clinical integrity and operational precision. Catalyst stands out as a company that's not only building value but protecting it — with the leadership, resources and investor conviction to succeed regardless of any challenge it may face.”

Orthopedic surgeon Dr. Steven Goldberg founded Catalyst OrthoScience in 2014.